Which term is defined as any untoward medical occurrence in a patient or trial subject administered a pharmaceutical product, regardless of causal relation?

Which term is defined as any untoward medical occurrence in a patient or trial subject administered a pharmaceutical product, regardless of causal relation?

• A. Adverse Event (AE)
• B. Adverse Drug Reaction (ADR)
• C. Audit
• D. Blinding/Masking

Answer: (A)

In trials, any untoward medical occurrence that happens in a patient or trial subject after they have received a pharmaceutical product, regardless of whether it’s related to the drug, is termed an Adverse Event. The key point is that causality isn’t required for this term—if something adverse occurs after administration, it’s recorded as an AE. This broad category captures all negative health changes, including those due to the underlying disease, other medications, or unknown factors. An Adverse Drug Reaction, by contrast, refers to an event in which a causal link to the drug is suspected or likely. So the event is not just any illness after dosing, but one that clinicians think may be caused by the drug. The other terms don’t fit the scenario: an audit is a review to ensure compliance with regulations and procedures, not a medical occurrence; blinding/masking is a study design technique used to prevent bias in assessment of outcomes. So the best answer is the broad Adverse Event, which covers any untoward medical occurrence after drug administration, without needing to establish causality.

In trials, any untoward medical occurrence that happens in a patient or trial subject after they have received a pharmaceutical product, regardless of whether it’s related to the drug, is termed an Adverse Event. The key point is that causality isn’t required for this term—if something adverse occurs after administration, it’s recorded as an AE. This broad category captures all negative health changes, including those due to the underlying disease, other medications, or unknown factors.

An Adverse Drug Reaction, by contrast, refers to an event in which a causal link to the drug is suspected or likely. So the event is not just any illness after dosing, but one that clinicians think may be caused by the drug.

The other terms don’t fit the scenario: an audit is a review to ensure compliance with regulations and procedures, not a medical occurrence; blinding/masking is a study design technique used to prevent bias in assessment of outcomes.

So the best answer is the broad Adverse Event, which covers any untoward medical occurrence after drug administration, without needing to establish causality.